ArticleBMC oral health2025
Development of a risk model for predicting cervical lymph node metastasis in major salivary gland carcinomas utilizing clinicopathological and ultrasound features.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesCervical lymph node (CLN) status is an important factor for the patients with major salivary gland carcinomas (MSGCs) with respect to the surgical methods, prognosis, and recurrence. Our aim is to develop a risk model that incorporates clinicopathological and ultrasound (US) features to predict the cervical lymph node metastasis (CLNM) in MSGCs.
methodsRetrospective data were gathered for 111 patients with MSGCs who underwent surgical treatment and US examinations at our institution from January 2016 to December 2022. Their clinicopathological and US data were documented and analyzed. Independent predictors predicting CLNM in MSGCs were screened through univariate and multivariate analysis. The nomogram model were built based on independent predictors using logistic regression. The evaluation of the model's performance was then conducted.
resultsThe clinicopathological and US factors of patient age, lesion size, US reported CLN-positive, histological type, and histological grade were identified as independent predictors for predicting CLNM in MSGCs. The nomogram model, which integrated these predictive factors, achieved an AUC of 0.923 (95% CI: 0.869 ~ 0.977), demonstrating good predictive performance and calibration. Decision curve analysis and clinical impact curve further confirmed its clinical usefulness.
conclusionsThe nomogram model we developed holds the potential to predict CLNM in MSGCs preoperatively, thereby enabling the provision of more precise therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.